We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Results: 3

1.
Figure 3.

Figure 3. From: Vascular Disease, ESRD, and Death: Interpreting Competing Risk Analyses.

Mortality is higher in those with vascular disease, independent of age or estimated GFR. Pre-ESRD and total mortality rates by category of (A) estimated GFR (ml/min per 1.73 m2) and (B) age, by presence of vascular disease.

Morgan E. Grams, et al. Clin J Am Soc Nephrol. 2012 October 5;7(10):1606-1614.
2.
Figure 2.

Figure 2. From: Vascular Disease, ESRD, and Death: Interpreting Competing Risk Analyses.

Competing risk analysis estimates absolute risk more accurately than standard Kaplan–Meier techniques when competing events are common. Cumulative incidence of pre-ESRD death by (A) standard Kaplan–Meier and (B) competing risk methods. No vascular disease (light gray shading and dotted line, 95% confidence intervals) versus vascular disease (dark gray shading and solid line, 95% confidence intervals). K–M, Kaplan–Meier.

Morgan E. Grams, et al. Clin J Am Soc Nephrol. 2012 October 5;7(10):1606-1614.
3.
Figure 1.

Figure 1. From: Vascular Disease, ESRD, and Death: Interpreting Competing Risk Analyses.

Absolute risk is overestimated by standard Kaplan–Meier analysis when competing events are common. Cumulative incidence of ESRD by (A) standard Kaplan–Meier and (B) competing risk methods. No vascular disease (light gray shading and dotted line, 95% confidence intervals) versus vascular disease (dark gray shading and solid line, 95% confidence intervals). K–M, Kaplan–Meier.

Morgan E. Grams, et al. Clin J Am Soc Nephrol. 2012 October 5;7(10):1606-1614.

Supplemental Content

Recent activity

Your browsing activity is temporarily unavailable.

Write to the Help Desk